Error: Could not add to watchlist. X

DWS Biotech

+ Watchlist
DWSBIOO:GR
143.65
EUR
5.06
3.40%
As of 1:59 AM EST on 2/9/2016.
Fund Type
Open-End Fund
52Wk Range
143.65 - 260.51
1 Yr Return
-28.65%
YTD Return
-32.93%
Previous Close
148.71
52Wk Range
143.65 - 260.51
1 Yr Return
-26.86%
YTD Return
-32.93%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 02/09/2016)
143.65
Total Assets (m EUR) (on 02/09/2016)
328.002
Inception Date
08/16/1999
Last Dividend (on 10/01/2015)
0.2830143
Dividend Indicated Gross Yield
0.25%
Fund Managers
NOUSHIN TURNER / THOMAS E BUCHER
Front Load Fee
5.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.50%
Expense Ratio
1.50%
Top Fund Holdings
Name Position Value % of Fund
Celgene Corp 438.00 k 46.67 m 9.11
Gilead Sciences Inc 371.65 k 37.95 m 7.41
Biogen Inc 124.00 k 34.38 m 6.71
Regeneron Pharmaceuticals Inc 63.00 k 33.54 m 6.55
Vertex Pharmaceuticals Inc 230.00 k 28.94 m 5.65
Incyte Corp 243.00 k 26.83 m 5.24
Amgen Inc 169.00 k 26.13 m 5.10
Alexion Pharmaceuticals Inc 147.00 k 25.36 m 4.95
Alkermes PLC 220.29 k 15.75 m 3.07
BioMarin Pharmaceutical Inc 170.40 k 15.54 m 3.03
Profile
DWS Biotech is an open-end fund incorporated in Germany. The Fund's objective is capital growth. The Fund invests primarily in biotech equities worldwide. The Fund focuses on companies in the U.S. and the portfolio may also include selected pharmaceutical and medical equipment firms. The Fund's investment is oriented on the MSCI BioTecnology Select Index.
ADDRESS
Deutsche Asset & Wealth Management
Investment GmbH
60612 Frankfurt am Main
Tel.: +49 (0) 69-910-12371
Fax: +49 (0) 69-910-19090
PHONE
-